These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2837619)

  • 1. Sequential use of conjugated estrogens and medroxyprogesterone in the climacteric syndrome: clinical and histological findings.
    Figueroa-Casas PR; Schlaen I
    Maturitas; 1988 Mar; 9(4):309-13. PubMed ID: 2837619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women.
    Gibbons WE; Moyer DL; Lobo RA; Roy S; Mishell DR
    Am J Obstet Gynecol; 1986 Feb; 154(2):456-61. PubMed ID: 3004222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of continuous versus sequential estrogen and progestin therapy in postmenopausal women.
    Clisham PR; de Ziegler D; Lozano K; Judd HL
    Obstet Gynecol; 1991 Feb; 77(2):241-6. PubMed ID: 1846438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new combination of conjugated equine oestrogens and medroxyprogesterone for treatment of climacteric complaints.
    Cullberg G; Knutsson F; Mattsson LA
    Maturitas; 1984 Jul; 6(1):55-63. PubMed ID: 6088950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy.
    Luciano AA; Turksoy RN; Carleo J; Hendrix JW
    Obstet Gynecol; 1988 Jan; 71(1):39-43. PubMed ID: 2827082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen and cyclical progestogen in postmenopausal hormone replacement therapy.
    MacLennan AH; MacLennan A; O'Neill S; Kirkgard Y; Wenzel S; Chambers HM
    Med J Aust; 1992 Aug; 157(3):167-70. PubMed ID: 1321944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
    Hargrove JT; Maxson WS; Wentz AC; Burnett LS
    Obstet Gynecol; 1989 Apr; 73(4):606-12. PubMed ID: 2538787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous estrogen/progestin therapy in menopause.
    Prough SG; Aksel S; Wiebe RH; Shepherd J
    Am J Obstet Gynecol; 1987 Dec; 157(6):1449-53. PubMed ID: 2827483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD; Landgren BM; Rymer J; Helmond FA;
    Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium.
    Gelfand MM; Ferenczy A
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):398-402. PubMed ID: 2548135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study to evaluate a new regimen to treat climacteric complaints with cyclic combined oestradiol valerate/medroxyprogesterone acetate.
    Hellberg D; Nilsson S
    Maturitas; 1987 Apr; 9(1):103-7. PubMed ID: 2955203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transvaginal sonography of the endometrium in postmenopausal women: monitoring the effect of hormone replacement therapy.
    Castelo-Branco C; Puerto B; Durán M; Gratacós E; Torné A; Fortuny A; Vanrell JA
    Maturitas; 1994 May; 19(1):59-65. PubMed ID: 7935033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin.
    Bewtra C; Kable WT; Gallagher JC
    J Reprod Med; 1988 Feb; 33(2):205-8. PubMed ID: 2832598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Provera the ideal progestogen for addition to postmenopausal estrogen therapy?
    Lane G; Siddle NC; Ryder TA; Pryse-Davies J; King RJ; Whitehead MI
    Fertil Steril; 1986 Mar; 45(3):345-52. PubMed ID: 3005052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group.
    Woodruff JD; Pickar JH
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1213-23. PubMed ID: 8178840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-progestin pharmacodynamics of the postmenopausal endometrium studied by thymidine labeling.
    Friedrich ER; Meyer JS
    Am J Obstet Gynecol; 1982 Jun; 143(3):352-9. PubMed ID: 6282125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate.
    Pickar JH; Yeh I; Wheeler JE; Cunnane MF; Speroff L
    Fertil Steril; 2001 Jul; 76(1):25-31. PubMed ID: 11438315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Lobo RA; McCormick W; Singer F; Roy S
    Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a continuous estrogen-progestin regimen in the menopausal patient.
    Weinstein L
    Obstet Gynecol; 1987 Jun; 69(6):929-32. PubMed ID: 3574823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of osteoporosis by medroxyprogesterone acetate in postmenopausal women.
    McNeeley SG; Schinfeld JS; Stovall TG; Ling FW; Buxton BH
    Int J Gynaecol Obstet; 1991 Mar; 34(3):253-6. PubMed ID: 1673944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.